Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CNSCure is an Indian biotechnology company dedicated to the discovery and development of novel therapeutics for central nervous system (CNS) disorders. The company focuses on addressing significant unmet medical needs in neurodegenerative diseases, including Alzheimer's and Parkinson's, as well as other neurological conditions like stroke. By leveraging its proprietary drug discovery platform, CNSCure aims to develop small molecule candidates with improved blood-brain barrier permeability and therapeutic efficacy. Headquartered in Hyderabad, the firm operates within the region's vibrant life sciences ecosystem and is supported by government-backed innovation grants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cnscure India.